Table III.

Univariate and multivariate analyses using Cox proportional hazard regression model for biochemical recurrence-free survival.

Predictor	Hazard ratio (95% confidence interval)	P-value
Univariate		0.022
miR-30c*ASF/SF2 status	2.61 (1.15–5.90)
Gleason score	9.00 (4.30–18.84)	<0.001
Preoperative PSA	1.01 (1.00–1.01)	0.010
Pathological tumor stage	5.83 (2.50–13.56)	<0.001
Surgical margin status	2.28 (0.98–5.30)	0.056
Multivariate		0.024
miR-30c*ASF/SF2 status	2.89 (1.15–7.22)
Gleason score	5.71 (2.46–13.29)	<0.001
Preoperative PSA	1.00 (1.00–1.03)	0.001
Pathological tumor stage	2.84 (1.03–7.79)	0.043

ASF/SF2, alternative splicing factor/splicing factor 2; miR, microRNA; PSA, PSA, prostate-specific antigen.